March 20, 2018 / 12:11 PM / a month ago

BRIEF-Durect Announces FDA Advisory Committee Meeting For Remoxy Er

Reuters Staff

1 Min Read

March 20 (Reuters) - Durect Corp:

* DURECT ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR REMOXY® ER

* DURECT CORP - ‍PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET DATE FOR REMOXY ER NDA IS AUGUST 7, 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.